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Abstract
Introduction: Corticosteroids are used in various 
clinical conditions that include many immune-mediated 
inflammatory diseases. Different side effects were 
described including cardiac arrhythmias. Most of those 
arrhythmias were in the form of bradycardia which 
usually occurs with high intravenous steroid doses. More 
significant arrhythmias and cardiac arrest were also 
described.  In this report we describe a case of bradycardia 
that developed after the use of oral corticosteroids. 
Case report: We report a case of bradycardia that 
developed in a 14 year-old male after receiving oral 
prednisone. The patient had steroid-sensitive nephrotic 
syndrome and presented with anasarca that started 
to develop few days prior to hospitalization. He had 
no underlying  heart disease. Vitals was normal. 
Investigations confirmed a new nephrotic relapse. Oral 
prednisone 80 mg / day divided into three doses was 
started. Albumin infusions were  initially given with 
intravenous furosemide to control the edema. Seven days 
after hospitalization, he developed bradycardia with a 
pulse rate of 50-60 per minute, which was less than 50% 
of the baseline heart rate. He didn’t develop significant 
symptoms and he had no other apparent  corticosteroids 
side effects. Cardiac evaluation and echocardiography 
were normal. Electrocardiogram revealed only sinus 
bradycardia.The bradycardia recovered after decreasing 
the dose of steroids to 60 mg PO every other day and he 
was discharged in stable condition a few days later.
Conclusion: Cardiac arrhythmias may develop 
with all forms of steroids including oral prednisone. 
Bradyarrhythmias can occur even with standard doses of 
oral prednisone.
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Introduction
Corticosteroids are used in various clinical conditions and 
have established therapeutic benefits in children affected 
by several autoimmune or rheumatic diseases. They have 
several cardiovascular adverse reactions, which are more 
common in adults than in children. The exact etiology of 
such reactions is unknown, but several mechanisms have 
been proposed.
Tachy- or brady-arrhythmias occur in 1-82% of 
adults and children taking steroids [1, 2]. Intravenous 
methylprednisolone (IVMP) in adults was reported to 
cause atrial fibrillation, supraventricular tachycardia, 
ventricular tachycardia, bradycardia, asystole and even 
death [3-8]. In children, such adverse reactions are 
less frequent. They were reported with various types, 
routes, and dosages of steroids. Ueda et al reported atrial 
fibrillation in two children within 24 hours after receiving 
a pulse therapy of IVMP [9], while bradycardia developed 
in 82% of children who received IVMP for refractory 
Kawasaki disease [2]. Dexamethasone was reported to 
cause bradycardia and hypertension in premature infants 
treated for bronchopulmonary dysplasia [10].
Despite numerous previous reports of steroid induced 
bradycardia when given through the intravenous or 
intramuscular route, using the standard dose (2 mg/ kg/ 
day up to 80 mg) of oral prednisone was not previously 
reported to cause bradycardia.
Case Report
A 14 year-old adolescent who suffered from steroid 
sensitive nephrotic syndrome was admitted with a relapse. 
He presented with anasarca that was started to develop 
few days prior to hospitalization. On admission, the blood 
pressure was 120/80 mmHg, Heart rate was 112 beats 
per minute (bpm) and respiratory rate was 19 per minute. 
Weight was 53kg and his height was 149 cm body surface 
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chronotropic or antiarrhythmic agents [5, 15] or temporary 
cardiac pacing [9] was described in the literature.
Conclusion
Bradycardia may complicate high dose oral prednisone 
therapy. It is advisable to obtain a baseline heart rate, 
an electrocardiogram and serum electrolytes before 
starting high dose steroid therapy in children. Monitoring 
the patient in hospital for a few days may also be 
considered. 
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area of 1.5 m2. Investigations showed nephrotic-range 
proteinuria, hypoalbuminemia, hypercholesterolemia. 
Hemoglobin level was 11.2 g/dL. He was treated with 
oral prednisone 80 mg/day divided into three doses. He 
was also given albumin 20% infusion and intravenous 
furosemide to control his edema. Three days later he 
showed clinical and laboratory remission.
Seven days after hospitalization, he developed 
bradycardia with a pulse rate of 50-60 bpm (50% less than 
the baseline heart rate) (Figure 1). He was asymptomatic 
apart from mild dizziness. His blood pressure was 
115/80 mmHg and peripheral perfusion was normal. 
Cardiovascular examination and echocardiogram were 
normal. Electrocardiogram revealed sinus bradycardia. 
Serum electrolytes, calcium and magnesium levels were 
normal. Prednisone dose was subsequently reduced to 60 
mg PO every other day. The patient’s heart rate returned 
to baseline 48 hours after reducing prednisolone dose. He 
was discharged in stable condition a few days later. 
Discussion
The exact etiology of steroid induced bradycardia is not 
known, but several mechanisms have been proposed. 
Severe bradycardia with or without hypotension was 
attributed to underlying heart disease [11], or rapid 
rate of infusion [7, 12]. Our patient had no evidence 
of underlying heart disease. Dexamethasone can cause 
bradycardia and hypertension in premature infants 
treated for bronchopulmonary dysplasia [11]. It has 
been suggested that alteration in the baroreceptor reflex 
could explain the association with the change in blood 
pressure seen in dexamethasone treated patients [10, 13]. 
However, it is also possible that bradycardia occurs as an 
idiosyncratic reaction to dexamethasone similar to what 
was described by Lucas et al [12].
Stimulation threshold of myocardial cells can be reduced 
secondary to direct inhibitory effect of the myocardium, 
altered sensitivity of adrenergic receptors, or abnormal 
serum electrolytes [6, 14]. Pudil et al showed diffuse 
accumulation of technetium Tc-99m pyrophosphate 
in the myocardium of two adults who developed 
bradycardia secondary to IVMP [6]. This may indicate 
a direct damage to the myocardium which may cause 
alteration in the electrolyte flux across the cell membrane. 
There was no evidence of myocardial inflammation by 
echocardiogram in our patient, although cardiac-specific 
inflammatory markers were not tested. Hall et al showed 
depression of cardiovascular alpha- and beta-1 adrenergic 
receptor sensitivity in animals receiving IVMP [14]. 
This may result in reduced myocardial sensitivity to 
catecholamines and altered urinary excretion of potassium 
and sodium [14]. Although our patient had normal serum 
electrolytes, he had significant hypoalbuminemia which 
reduces total calcium concentration in the serum and may 
lead to altered myocardial sensitivity. Abnormal serum 
electrolytes were also observed in two out of five children 
who developed bradycardia after receiving IVMP for 
refractory Kawasaki disease [2].
Bradycardia is usually asymptomatic; though 
palpitations, loss of consciousness and even cardiac 
arrest were described [1, 3, 7-9, 12]. It will usually 
resolve spontaneously after hours to days of withdrawing 
or reducing the dose of the offending drug, as happened 
with our patient. However, the need for administration of 
Figure 1:Heart rate in relation to the dose of oral prednisone in reported patient 
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